calcitonin gene-related peptide fragments (Metabolic)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Namecalcitonin gene-related peptide fragments (Metabolic)
Drug Alias Nameosteoporosis treatments (Metabolic)MBP-0260MBP-0250
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionAmylin receptor agonistsAdrenomedullin receptor agonistsBone synthesis stimulants
TargetsAdrenomedullin receptorAmylin Receptor
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAuckland Uniservices Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPolynovo
Active IndicationsN/A
Inactive IndicationsOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A